Kedrion is proud to support the “Guelfo Marcucci” Award, dedicated to congenital coagulopathies, and the “Fabrizio Fabbrizzi” Award, which promotes studies on the therapeutic use of plasma proteins.
Today, at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico in Milan, the 2024 Research Awards ceremony took place, organized by Fondazione Carlo Erba with the support of Kedrion and in collaboration with the National Institute of Molecular Genetics (INGM). The event, hosted in the “Romeo ed Enrica Invernizzi” Pavilion, brought together representatives from the scientific, institutional, and corporate worlds, along with the young award-winning researchers.
The day opened with greetings from Prof. Sergio Abrignani, Scientific Director of INGM and Board Member of Fondazione Carlo Erba, followed by an introduction from Paolo Marcucci, President of Fondazione Carlo Erba, and remarks from Prof. Pier Mannuccio Mannucci of Ospedale Maggiore Policlinico in Milan. The highlight was the presentation of the winning projects and the awarding of prizes and plaques to the young researchers, who illustrated the results and future prospects of their work.
Awards and a shared commitment
Fondazione Carlo Erba has always been committed to promoting biomedical research, granting annual awards and scholarships to young Italian researchers. In particular:
- The “Guelfo Marcucci” Award, supported by Kedrion since 2017, honors the memory of Kedrion’s founder, Guelfo Marcucci, and rewards innovative projects in the field of congenital coagulopathies.
- The “Fabrizio Fabbrizzi” Award, established in 2020 with Kedrion’s support and named after Dr. Fabbrizzi, promotes studies on the therapeutic use of plasma proteins.
- The “Cecilia Cioffrese” Awards, funded by a bequest from Mrs. Cioffrese, recognize outstanding research in oncology and viral diseases.
Awarded projects in 2024
- Guelfo Marcucci Awards:
- Alessandro Di Minno (University of Naples Federico II) – for research on new gene therapy strategies using adeno-associated viral vectors in people with hemophilia.
- Andrea Giachi (Policlinico Ca’ Granda Hospital, Milan) – for proteomic analysis aimed at discovering biomarkers of hemarthrosis and joint health in people with hemophilia.
- Fabrizio Fabbrizzi Award:
- Michela Milani (San Raffaele University of Milan – Telethon Institute for Gene Therapy) – for developing an in vivo platelet gene therapy mediated by lentiviral vectors for hemophilia A.
- Cecilia Cioffrese Awards:
- Margherita Ambrosini (University of Milan) – for studying determinants of sensitivity and resistance to targeted treatments in the pre-operative phase of colon cancer.
- Camilla Albano (University of Turin) – for research on the role of lipid metabolism in HSV-1 infection, with implications for viral replication and potential therapeutic strategies.
Innovation, impact, and young excellence
The awarded projects stand out for their high level of scientific and technological innovation, tangible impact on patient health, and ability to bridge basic research and clinical application. All winners are young researchers with experience in leading Italian and international centers, confirming the vitality of Italian research on the global stage.
“The partnership between Fondazione Carlo Erba and Kedrion is a virtuous example of collaboration between non-profit organizations and industry, aimed at promoting scientific research and rewarding merit. Through these awards, Fondazione Carlo Erba and Kedrion reaffirm their commitment to supporting research and young talent, with the goal of improving patients’ quality of life and fostering scientific innovation,” said Paolo Marcucci, President of Fondazione Carlo Erba.
Information and calls for applications
All details on calls for applications, participation procedures, and the history of the awards are available on the Fondazione Carlo Erba website: www.fondazionecarloerba.org.
